Showing results (21-30 of 183) with videos related to
Sort By:
Pageof 19
Statistics in Biopharmaceutical Research|April 25, 2017
Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step toward Pragmatism in Benefit:risk EvaluationScott R Evans, Dean FollmannBiometrics|December 15, 2017
Sieve analysis using the number of infecting pathogensDean Follmann, Chiung-Yu HuangClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2020
Resist the Temptation of Response-Adaptive RandomizationMichael Proschan, Scott EvansStatistics in Medicine|September 12, 2018
Half blind superiority tests for clinical trials of anti-infective drugsDean Follmann, Erica Brittain, Keith LumbardStatistics in Medicine|April 9, 2022
Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinatedDean Follmann, Michael Fay, Craig MagaretBiometrics|August 8, 2007
Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpointErica Brittain, Dean Follmann, Song YangStatistics in Medicine|February 18, 2017
Semiparametric pseudoscore for regression with multidimensional but incompletely observed regressorZonghui Hu, Jing Qin, Dean FollmannStatistics in Medicine|June 18, 2016
Who really gets strep sore throat? Confounding and effect modification of a time-varying exposure on recurrent eventsDean Follmann, Chiung-Yu Huang, Erin GabrielClinical Trials (London, England)|November 30, 2013
Discordant minimum inhibitory concentration analysis: a new path to licensure for anti-infective drugsDean Follmann, Erica Brittain, John H PowersPageof 19